Glioma is the most common primary central nervous system tumor, accounting for more than half of all primary intracranial tumors. 1 According to the World Health Organization (WHO) classification scheme, gliomas can be divided into four types: mixed glioma, neuroepithelial tumor, gliomatosis cerebri, and neuroglioma. 2 The transcription coactivator TAZ, which contains 400 amino acids, is one of the most important downstream effectors of the mammalian Hippo pathway. Its structure consists of a transcriptional-enhanced associate domain (TEAD)-binding region (TB), a WW region, a curly helix structure, a transcription activation region, and a PDZ motif at the C-terminus. 3,4 TAZ is involved in the transcriptional co-activation of downstream target factors, and the regulation of cell proliferation, apoptosis, and migration. 5,6 In recent years, it has been found that the expression of TAZ in gastric cancer, non-small